Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other 1

Conditions

Multiple Myeloma 13Precursor Cell Lymphoblastic Leukemia-Lymphoma 5Burkitt Lymphoma 5Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 3Immunoglobulin Light-chain Amyloidosis 3Recurrence 2Neoplasms 2Neoplasm Metastasis 2Lymphoma, Mantle-Cell 2Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 1Lung Neoplasms 1Leukemia, Myeloid, Acute 1Leukemia, Myeloid, Accelerated Phase 1Leukemia, Biphenotypic, Acute 1Fatigue 1Dyspnea 1Down Syndrome 1Cholangiocarcinoma 1Castration-Resistant Prostate Carcinoma 1Carcinoma, Non-Small-Cell Lung 1Carcinoma, Hepatocellular 1Brain Neoplasms 1Blast Crisis 1

Interventions

dexamethasone acetate 1dexamethasone 21-phosphate 1auricularum 1Dexamethasone 1Calcium Dobesilate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Active not recruiting × Dyspnea × dexamethasone 21-phosphate × Clear all
NCT03367156 2025-11-12

Dexamethasone in Controlling Dyspnea in Patients With Cancer

M.D. Anderson Cancer Center

Phase 2 Active not recruiting
135 enrolled 19 charts
Other

Dyspnea, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡